Identification of Markers for Determining the Efficacy of Vitamin D Receptor Activator Therapy in Stage 3/4 CKD Patients

NCT02018133 · clinicaltrials.gov ↗

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

CKD Stage 3/4

Interventions

DRUG: Vitamin D 2mg daily for 2 weeks oral paricalcitol
DRUG: Placebo

Sponsor

University of Illinois at Chicago

Collaborators

[object Object]